Top highlights include: why you should update your medicine cabinet, a year of learning during the pandemic, and forecasting for COVID-19 hot spots.
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the right diagnosis for patients.
Thank you to our staff at Mayo Clinic who step up daily during this time of need to provide access to testing during the global pandemic. We appreciate each one of you and all the sacrifices you personally have made throughout this past year.
Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new comprehensive Controlled Substance Monitoring Panel, developed by the Clinical and Forensic Toxicology Laboratory at Mayo Clinic Laboratories, offers in-depth analysis on more than 70 different prescription medications and illicit substances to provide clinicians with details and interpretations on patients’ controlled substance use lacking in other laboratory assays.
This week’s research roundup features a study on the management of patients with giant cell myocarditis.
Top highlights include: The impact COVID-19 has had on women, SARS-CoV-2 mutations explained, and expert answers about the new COVID-19 vaccine.
As she heads toward retirement at the end of March, Rita Baird looks back on her career at Mayo Clinic Laboratories and discusses her role working with MCL clients as a regional service representative.
This week’s research roundup features a phase III study of lenalidomide plus R-CHOP versus placebo plus R-CHOP in previously untreated patients With ABC-type diffuse large b-cell lymphoma.
Top highlights include: a list of COVID-19 drugs and how they work, policy changes in visitor policy at Mayo Clinic in Rochester, and what to know about kids going back to school.
This week’s research roundup features a study on the sequencing of 53,831 diverse genomes from the NHLBI TOPMed program.
Top highlights include: side effects of the COVID-19 vaccine, tackling the latest pandemic topics, and World Encephalitis Day.
A supervisor in the lab that's at the heart of Mayo Clinic Laboratories' COVID-19 testing, Dave Majewski's job has changed dramatically in the last year, as he went from overseeing about 40 staff members to more than 240 in a lab that now runs 24/7.
This week’s research roundup features a study on trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.